Printed From BioPortfolio.com

FDA Okays Lilly's Breast Cancer Drug Verzenio

21:42 EDT 28 Sep 2017 | FinanzNachrichten

INDIANAPOLIS (dpa-AFX) - The U.S. Food and Drug Administration approved Eli Lilly and Co.'s (LLY) Verzenio or abemaciclib to treat adult patients who have hormone receptor (HR)-positive, human epi...

Original Article: FDA Okays Lilly's Breast Cancer Drug Verzenio

Give dad the gift of knowledge. Order his DNA Ancestry kit this Father's Day for $99 at 23andMe! Ord

Quick Links
Advanced Search | Login | Subscribe | RSS

Quick Search

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Endocrine Disorders
Endocrine disorders are grouped into two categories: hormone imbalance - when a gland produces too much or too little of an endocrine hormone development of lesions (such as nodules or tumors) in the endocrine system, which may or may not affect...

News Quicklinks

Search Biotech, Medical and Healthcare News

Biotech News by Article Type

Biotech News by Location

BioPortfolio Bloggers

Publishing Your News on BioPortfolio

Recent Visitor News Searches

Topics

FDA Okays Lilly's Breast Cancer Drug Verzenio

More From BioPortfolio on "FDA Okays Lilly's Breast Cancer Drug Verzenio"

Relevant Topics

News Quicklinks